Perioperative management of aortic stenosis in patients undergoing non-cardiac surgery.

aortic stenosis (AS) aortic valve replacement (AVR) non-cardiac surgery outcomes valvular heart disease (VHD)

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 16 01 2023
accepted: 06 03 2023
medline: 24 4 2023
pubmed: 24 4 2023
entrez: 24 04 2023
Statut: epublish

Résumé

Aortic stenosis is one of the most common cardiac valve pathologies in the world and its prevalence increases with age. Although previously associated with increased perioperative mortality, more recent studies suggest that mortality rates may be decreasing. Recent guidelines suggest that major non-cardiac surgery can be performed safely in asymptomatic severe aortic stenosis patients with close hemodynamic monitoring. Among symptomatic patients, the guidelines recommend aortic valve intervention prior to major non-cardiac surgery because of a reduction in the incidence of postoperative heart failure and improved rates of long-term overall survival. This review provides a comprehensive and contemporary review of the perioperative management of patients with severe aortic valve stenosis.

Identifiants

pubmed: 37089878
doi: 10.3389/fcvm.2023.1145290
pmc: PMC10117820
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1145290

Informations de copyright

© 2023 Herrera, Smith, Mauermann, Nkomo and Luis.

Déclaration de conflit d'intérêts

SL is a consultant for Medtronic, SOBI Pharmaceuticals, and Kiniksa Pharmaceuticals. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Cardiol. 2017 Aug 1;240:145-153
pubmed: 28431770
J Am Heart Assoc. 2017 Oct 11;6(10):
pubmed: 29021274
Circ J. 2020 Jun 25;84(7):1173-1182
pubmed: 32435000
Eur Heart J. 2003 Jul;24(13):1231-43
pubmed: 12831818
Eur Heart J. 2022 Oct 14;43(39):3826-3924
pubmed: 36017553
Eur Heart J. 2014 Sep 14;35(35):2372-81
pubmed: 24553722
J Cardiovasc Med (Hagerstown). 2017 Feb;18(2):109-113
pubmed: 26885982
J Am Coll Cardiol. 2014 Dec 9;64(22):e77-137
pubmed: 25091544
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
JAMA Netw Open. 2022 Jul 1;5(7):e2220689
pubmed: 35797045
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
J Nucl Cardiol. 2017 Aug;24(4):1200-1213
pubmed: 26979307
Am J Cardiol. 2001 May 15;87(10):1216-7; A7
pubmed: 11356405
Chest. 2005 Oct;128(4):2944-53
pubmed: 16236971
Mayo Clin Proc. 2020 Apr;95(4):727-737
pubmed: 32247346
Arch Intern Med. 2011 Feb 14;171(3):226-33
pubmed: 21325112
Circulation. 2021 Feb 2;143(5):e72-e227
pubmed: 33332150
Circulation. 2021 Jun 22;143(25):e1088-e1114
pubmed: 33980041
Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):193-200
pubmed: 23481524
Mayo Clin Proc. 2018 Apr;93(4):488-508
pubmed: 29622096
Circ J. 2015;79(4):867-72
pubmed: 25739571
Prog Cardiovasc Dis. 2014 May-Jun;56(6):565-71
pubmed: 24838132
Circulation. 2005 Jun 21;111(24):3290-5
pubmed: 15956131

Auteurs

Roberto A Herrera (RA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.

Mark M Smith (MM)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States.

William J Mauermann (WJ)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States.

Vuyisile T Nkomo (VT)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.

Sushil Allen Luis (SA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.

Classifications MeSH